MedTrace Logo

Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

NCT00156611 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2006-09-12

No results posted yet for this study

Summary

The Rio Study is a randomized, double blinded German- Swiss- Austria multi-centre trial on the efficacy and safety of ReoPro together with interventional recanalization of TASC D lesions in the SFA and popliteal artery.

Conditions

  • Arterial Occlusive Diseases

Interventions

PROCEDURE

Balloon Angioplasty

DRUG

ReoPro

Sponsors & Collaborators

  • University of Bern

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Gunnar Tepe, MD · University Hospital of Tuebingen

  • Iris Baumgartner, MD · University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Completion
2009-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156611 on ClinicalTrials.gov